Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Massachusetts General Hospital
University of California, San Francisco
Northwestern University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins